SMT201600096B - Composizione farmaceutica comprendente (s)-2-(2oxopirrolidin-1-il)butanamide - Google Patents

Composizione farmaceutica comprendente (s)-2-(2oxopirrolidin-1-il)butanamide

Info

Publication number
SMT201600096B
SMT201600096B SM201600096T SM201600096T SMT201600096B SM T201600096 B SMT201600096 B SM T201600096B SM 201600096 T SM201600096 T SM 201600096T SM 201600096 T SM201600096 T SM 201600096T SM T201600096 B SMT201600096 B SM T201600096B
Authority
SM
San Marino
Prior art keywords
butanamide
pharmaceutical composition
composition including
pharmaceutical
composition
Prior art date
Application number
SM201600096T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Lab S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab S A filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab S A
Publication of SMT201600096B publication Critical patent/SMT201600096B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SM201600096T 2011-12-16 2016-04-05 Composizione farmaceutica comprendente (s)-2-(2oxopirrolidin-1-il)butanamide SMT201600096B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11009922 2011-12-16

Publications (1)

Publication Number Publication Date
SMT201600096B true SMT201600096B (it) 2016-07-01

Family

ID=47324162

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600096T SMT201600096B (it) 2011-12-16 2016-04-05 Composizione farmaceutica comprendente (s)-2-(2oxopirrolidin-1-il)butanamide

Country Status (11)

Country Link
EP (1) EP2790695B1 (it)
CY (1) CY1117398T1 (it)
DK (1) DK2790695T3 (it)
ES (1) ES2568075T3 (it)
HR (1) HRP20160278T1 (it)
HU (1) HUE026791T2 (it)
PL (1) PL2790695T3 (it)
RS (1) RS54692B1 (it)
SI (1) SI2790695T1 (it)
SM (1) SMT201600096B (it)
WO (1) WO2013087563A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116459225B (zh) * 2023-04-26 2023-11-10 东莞市金美济药业有限公司 一种艾拉戈克钠片及其制备工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011507829A (ja) * 2007-12-21 2011-03-10 アレンビック・リミテッド 新規なレベチラセタムの被覆徐放性医薬組成物
JP2011513360A (ja) 2008-03-03 2011-04-28 ユセベ ファルマ ソシエテ アノニム 医薬溶液、調製方法及び治療的使用
JP2010024156A (ja) 2008-07-16 2010-02-04 Ucb Pharma Sa レベチラセタムを含む医薬組成物
US20100172979A1 (en) 2008-12-24 2010-07-08 Zhongshui Yu Controlled-release formulations
EP2563340A2 (en) 2010-04-26 2013-03-06 Mahmut Bilgic Water soluble pharmaceutical composition

Also Published As

Publication number Publication date
SI2790695T1 (sl) 2016-09-30
HUE026791T2 (en) 2016-07-28
PL2790695T3 (pl) 2016-07-29
EP2790695B1 (en) 2016-03-16
RS54692B1 (en) 2016-08-31
ES2568075T3 (es) 2016-04-27
WO2013087563A1 (en) 2013-06-20
EP2790695A1 (en) 2014-10-22
DK2790695T3 (en) 2016-04-18
HRP20160278T1 (hr) 2016-05-20
CY1117398T1 (el) 2017-04-26

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
DK2694038T3 (da) Farmaceutisk sammensætning
CO6852076A2 (es) Composiciones farmacéuticas inhalables
BR112014003052A2 (pt) composições farmacêuticas
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK3246018T3 (da) Farmaceutisk sammensætning
CO6930367A2 (es) Composiciones farmaceúticas
GT201200303A (es) Formulaciones farmacéuticas
BR112013014644A2 (pt) composição farmacêutica e complexo
GB201118232D0 (en) Pharmaceutical composition
EE201300005A (et) Ravimkoostis
CO6940426A2 (es) Formulaciones farmacéuticas
DK2897594T3 (da) Farmaceutisk sammensætning
DK2815752T3 (da) Oral farmaceutisk sammensætning
BR112014000015A2 (pt) formulação
DK3178474T3 (da) Farmaceutisk formulering omfattende inositol
HK1189158A1 (en) Pharmaceutical composition
BR112014009319A2 (pt) compostos farmacêuticos
SMT201500005B (it) Composizione framaceutica inalabile
BR112014015885A2 (pt) preparação farmacêutica
BR112015002646A2 (pt) composto e composição farmacêutica
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en) Pharmaceutical composition